Deprescribing Aspirin for Older Adults

Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This online, survey-based experiment will include 2,400 adults who are 65 years and older (n=1,200 each from the United States and Australia). Each participant will be asked to share their opinions on a hypothetical patient scenario developed by our multidisciplinary team. This work is expected to significantly contribute to the understanding of how older adults make decisions about deprescribing medications. The long-term goal is to enhance communication between older adults and clinicians so that medication regimens are optimized and align with care preferences. These results will directly inform future research on the impact of communication choices in clinical practice.

Who Is on the Research Team?

SV

Sarah Vordenberg, PharmD, MPH

Principal Investigator

University of Michigan

Are You a Good Fit for This Trial?

This trial is for adults aged 65 and older living in the United States or Australia. It's designed to gather their views on stopping aspirin through an online survey, focusing on a hypothetical patient scenario.

Inclusion Criteria

Reside in Australia or the United States
I am 65 years old or older.

Exclusion Criteria

Unable to read survey written in English

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Survey

Participants complete an online survey sharing their opinions on a hypothetical patient scenario

1 week
Online participation

Follow-up

Participants are monitored for any additional feedback or insights post-survey

2 weeks

What Are the Treatments Tested in This Trial?

Trial Overview

The study tests how providing less information versus additional harm information affects older adults' attitudes towards deprescribing aspirin. The goal is to improve communication between patients and doctors about medication choices.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Source of recommendation - PhysicianExperimental Treatment2 Interventions
Group II: Source of recommendation - PharmacistExperimental Treatment2 Interventions
Group III: Source of information - AIExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

University of Sydney

Collaborator

Trials
208
Recruited
417,000+